{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:48:06Z","timestamp":1792507686703,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006327","name":"National Institute of Radiological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.nucmedbio.2020.04.007","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T10:55:41Z","timestamp":1588330541000},"page":"138-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["[11C]phosgene: Synthesis and application for development of PET radiotracers"],"prefix":"10.1016","volume":"92","author":[{"given":"Toshimitsu","family":"Fukumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakana","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanao","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0005","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0020-708X(81)90163-0","article-title":"The synthesis of some 11C-labeled antiepileptic drugs with potential utility as radiopharmaceuticals: hydantoins and barbiturates","volume":"32","author":"Roeda","year":"1981","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0010","first-page":"255","article-title":"Synthesis of [2-11C]5,5-dimethyl-2,4-oxazolidinedione for studies with positron tomography","volume":"23","author":"Ginos","year":"1982","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0020-708X(82)90064-3","article-title":"Synthesis and in vivo characteristics of [2-11C]5,5-dimethyloxazolidine-2,4-dione (DMO)","volume":"33","author":"Berridge","year":"1982","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1021\/jm00370a013","article-title":"Synthesis, receptor binding, and target-tissue uptake of carbon-11 labeled carbamate derivatives of estradiol and hexestrol","volume":"27","author":"Ouellet","year":"1984","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0025","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0020-708X(84)90005-X","article-title":"A new, simple, high-yield synthesis of \u201cno-carrier-added\u201d 11C-labelled DMO","volume":"35","author":"Diksic","year":"1984","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0030","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0020-708X(85)90030-4","article-title":"Synthesis of [2-11C]5,5-dimethyl-2,4-oxazolidinedione with and without added dimethyl carbonate as a carrier for studies with positron tomography","volume":"36","author":"Ginos","year":"1985","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0035","first-page":"1957","article-title":"Synthesis of \u201cno-carrier-added\u201d carbon-11 SarCNU: the sarcosinamide analog of the chemotherapeutic agent BCNU","volume":"29","author":"Conway","year":"1988","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0883-2889(91)90103-8","article-title":"PET studies of potential chemotherapeutic agents--X. Synthesis of \u201cno-carrier-added\u201d 11C-HECNU: the hydroxyethyl analog of the chemotherapeutic agent BCNU","volume":"42","author":"Conway","year":"1991","journal-title":"Int J Rad Appl Instrum A"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0883-2889(91)90032-V","article-title":"Asymmetric synthesis of a precursor for the automated radiosynthesis of S-(3\u2032-t-butylamino-2\u2032-hydroxypropoxy)-benzimidazol-2-[11C]one (S-[11C]CGP 12177) as a preferred radioligand for beta-adrenergic receptors","volume":"42","author":"Brady","year":"1991","journal-title":"Int J Rad Appl Instrum"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF01731838","article-title":"Synthesis and in vivo studies of a specific monoamine oxidase B inhibitor: 5-[4-(benzyloxy)phenyl]-3-(2-cyanoethyl)- 1,3,4-oxadiazol-[11C]-2 3H-one","volume":"23","author":"Bernard","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0968-0896(96)00256-8","article-title":"Synthesis of [11C]RPR-72840A and its evaluation as a radioligand for the serotonin reuptake site in positron emission tomography","volume":"5","author":"Roeda","year":"1997","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0014-2999(97)01528-8","article-title":"A novel beta-adrenoceptor ligand for positron emission tomography: evaluation in experimental animals","volume":"343","author":"van Waarde","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0039-128X(98)00013-0","article-title":"Synthesis and in vitro evaluation of [carbonyl-11C]estramustine and [carbonyl-11C]estramustine phosphate","volume":"63","author":"Lidstr\u00f6m","year":"1998","journal-title":"Steroids"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0969-8043(99)00051-2","article-title":"An automated radiosynthesis of 2-[11C]thymidine using anhydrous [11C]urea derived from [11C]phosgene","volume":"51","author":"Steel","year":"1999","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0969-8051(01)00263-3","article-title":"Two routes to [11C-carbonyl]organo-isocyanates utilizing [11C]phosgene ([11C]organo-isocyanates from [11C]phosgene)","volume":"28","author":"Brown","year":"2001","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0080","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0960-894X(03)00215-4","article-title":"Synthesis and in vivo imaging properties of [11C]befloxatone: a novel highly potent positron emission tomography ligand for mono-amine oxidase-a","volume":"13","author":"Dolle","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0085","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1021\/jo0498157","article-title":"Studies toward labeling cytisine with [11C]phosgene:rapid synthesis of a \u03b4-lactam involving a new chemoselective lithiation\u2212annulation method","volume":"69","author":"Rouden","year":"2004","journal-title":"J Org Chem"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0090","first-page":"3229","article-title":"Radiosynthesis and pharmacological evaluation of [11C]EMD-95885: a high affinity ligand for NR2B-containing NMDA receptors","volume":"12","author":"Roger","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.mnm.0000134320.39903.75","article-title":"Preparation and pharmaceutical evaluation for clinical application of high specific activity S-(\u2212)[11C]CGP-12177, a radioligand for beta-adrenoreceptors","volume":"25","author":"Nishijima","year":"2004","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0100","first-page":"212","article-title":"A novel and efficient synthesis of [2-11C]5-fluorouracil for prognosis of cancer chemotherapy","volume":"10","author":"Seki","year":"2007","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jlcr.1492","article-title":"Radiosynthesis of (S)-5-methoxymethyl-3-[6-(4,4,4-trifluorobutoxy)benzo[d]isoxazol-3-yl] oxazolidin-2-[11C]one ([11C]SL25.1188), a novel radioligand for imaging monoamine oxidase-B with PET","volume":"58","author":"Bramoull\u00e9","year":"2008","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0110","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.apradiso.2010.03.012","article-title":"Radiosynthesis of [2-11C-carbonyl]dantrolene using [11C]phosgene for PET","volume":"68","author":"Takada","year":"2010","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0115","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.bmcl.2011.03.002","article-title":"[11C]sorafenib: radiosynthesis and preliminary PET study of brain uptake in P-gp\/Bcrp knockout mice","volume":"21","author":"Asakawa","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0120","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1016\/j.bmcl.2011.09.102","article-title":"Radiosynthesis of three [11C]ureido-substituted benzenesulfonamides as PET probes for carbonic anhydrase IX in tumors","volume":"21","author":"Asakawa","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0125","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.bmcl.2012.04.049","article-title":"Utilization of [11C]phosgene for radiosynthesis of N-(2-{3-[3,5-bis(trifluoromethyl)]phenyl[11C]ureido}ethyl)glycyrrhetinamide, an inhibitory agent for proteasome and kinase in tumors","volume":"22","author":"Asakawa","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bmcl.2011.11.055","article-title":"Synthesis of [11C]uric acid, using [11C]phosgene, as a possible biomarker in PET imaging for diagnosis of gout","volume":"22","author":"Yashio","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1021\/cn500269g","article-title":"Development of [11C]MFTC for PET imaging of fatty acid amide hydrolase in rat and monkey brains","volume":"6","author":"Kumata","year":"2015","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0140","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1016\/j.bmcl.2017.08.061","article-title":"[11C]BCTC: radiosynthesis and in vivo binding to transient receptor potential vanilloid subfamily member 1 (TRPV1) receptor in the mouse trigeminal nerve","volume":"27","author":"Kumata","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0145","first-page":"149","article-title":"Radiosynthesis of 11C-phenytoin using a DEGDEE solvent for clinical PET studies","volume":"6","author":"Kanai","year":"2018","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0150","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/j.bmc.2019.06.037","article-title":"Radiosynthesis and evaluation of a novel monoacylglycerol lipase radiotracer: 1,1,1,3,3,3-hexafluoropropan-2-yl-3-(1-benzyl-1H-pyrazol-3-yl)azetidine-1-[11C]carboxylate","volume":"27","author":"Mori","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41181-019-0056-5","article-title":"Radiosynthesis and in vivo evaluation of 11C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptors","volume":"4","author":"Kawamura","year":"2019","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jlcr.3596","article-title":"Recent progress in [11C]carbon dioxide ([11 C]CO2) and [11C]carbon monoxide ([11C]CO) chemistry","volume":"61","author":"Taddei","year":"2018","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0165","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1039\/c3cc42236d","article-title":"11CO2 fixation: a renaissance in PET radiochemistry","volume":"49","author":"Rotstein","year":"2013","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41181-019-0073-4","article-title":"[11C]carbon monoxide: advances in production and application to PET radiotracer development over the past 15 years","volume":"4","author":"Taddei","year":"2019","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0175","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1039\/C6CS00310A","article-title":"11C=O bonds made easily for positron emission tomography radiopharmaceuticals","volume":"45","author":"Rotstein","year":"2016","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0180","article-title":"The development of 11C-carbonylation chemistry: a systematic view","author":"Eriksson","year":"2020","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0185","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1002\/anie.201915414","article-title":"[11C]carbonyl difluoride-a new and highly efficient [11C]carbonyl group transfer agent","volume":"59","author":"Jakobsson","year":"2020","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0047-0740(82)90089-4","article-title":"An on-line synthesis of \u201cno-carrier-added\u201d [11C]phosgene","volume":"9","author":"Diksic","year":"1982","journal-title":"Int J Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0195","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0020-708X(81)90081-8","article-title":"U.V.-induced on-line synthesis of 11C-phosgene and the preparation of some of its derivatives","volume":"32","author":"Roeda","year":"1981","journal-title":"Int Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0200","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0020-708X(78)90114-X","article-title":"Preparation of 11COCl2","volume":"29","author":"Brinkman","year":"1978","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0205","first-page":"175","article-title":"The production of\u2019 11C-phosgene without added carrier","volume":"33","author":"Roeda","year":"1978","journal-title":"Radiochem Radioanal Lett"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0210","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/0020-708X(83)90296-X","article-title":"11C-labelled phosgene: an improved procedure and synthesis device","volume":"34","author":"Crouzel","year":"1983","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0215","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0883-2889(87)90042-6","article-title":"A new synthesis of carbon-11 labeled phosgene","volume":"38","author":"Landais","year":"1987","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0220","first-page":"306","article-title":"A simplified production of high specific activity [11C] labeled phosgene, 11COCl2","volume":"40","author":"Link","year":"1997","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0969-8051(01)00310-9","article-title":"A simplified and improved synthesis of [11C]phosgene with iron and iron (III) oxide","volume":"29","author":"Nishijima","year":"2002","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tetlet.2009.11.011","article-title":"A simplified [11C]phosgene synthesis","volume":"51","author":"Bramoull\u00e9","year":"2010","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nucmedbio.2009.08.008","article-title":"Simple and effective method for producing [11C]phosgene using an environmental CCl4 gas detection tube","volume":"37","author":"Ogawa","year":"2010","journal-title":"Nucl Med Biol"},{"issue":"Suppl1","key":"10.1016\/j.nucmedbio.2020.04.007_bb0240","first-page":"S202","article-title":"Development of versatile synthesis equipment for multiple production of PET radiopharmaceuticals","volume":"50","author":"Fukumura","year":"2007","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0245","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0883-2889(86)90043-2","article-title":"Use of 11C as a tracer for studying the synthesis of radiolabelled compounds\u2014II: 2-[11C]-5,5-diphenylhydantoin from [11C]cyanide","volume":"37","author":"Emran","year":"1986","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0250","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/cber.19871200816","article-title":"Reaktionen mit Diazoazolen, VIII Synthesen von Azolo[5,1-d]-1,2,3,5-tetrazin-4(3H)-onen","volume":"120","author":"Ege","year":"1987","journal-title":"Chem Ber"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0255","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jlcr.2580230514","article-title":"Synthesis of 4-(3-t-butylamino-2-hydroxypropoxy)-benzimidazol-2(11C)-one (cgp 12177)","volume":"23","author":"Boullais","year":"1986","journal-title":"J Label Comp Radiopharm"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0260","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jlcr.2580290609","article-title":"Asymmetric synthesis of (2S)-and (2R)-4-(3-t-butylamino-2-hydroxypropoxy)-benzimidazol-2-[11C]-one ((S)-and (R)-[11C]-CGP 12177) from optically active precursors","volume":"29","author":"Hammadi","year":"1991","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0265","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/01.CIR.87.4.1169","article-title":"Positron emission tomography with [11C]CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy","volume":"87","author":"Merlet","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0270","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/slct.201803561","article-title":"Rapid and efficient synthesis of 11C-labeled benzimidazolones using [11C]carbon dioxide","volume":"4","author":"Horkka","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0275","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/(SICI)1099-1344(199905)42:5<437::AID-JLCR202>3.0.CO;2-I","article-title":"Synthesis of [11C]LU 29-066, a 5-HT2 receptor antagonist","volume":"42","author":"Amokhtari","year":"1999","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0280","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1016\/j.tetlet.2006.05.143","article-title":"A new convenient method for the synthesis of [2-11C]thymine utilizing [11C]phosgene","volume":"47","author":"Ohkura","year":"2006","journal-title":"Tetradedron Lett"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0285","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3987\/COM-08-S(N)61","article-title":"Synthesis of 11C-labeled uracil derivative for a PET tracer targeting thymidine phosphorylase","volume":"76","author":"Takahashi","year":"2008","journal-title":"Heterocyoles"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jlcr.1702","article-title":"Radiosynthesis of N-[4-(4-fluorobenzyl)piperidin-1-yl]-N\u2019-(2-[11C]oxo-1,3-dihydrobenzimidazol-5-yl)oxamide, a NR2B-selective NMDA receptor antagonist","volume":"53","author":"Labas","year":"2010","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0295","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ejmech.2018.08.019","article-title":"Synthesis, pharmacology and preclinical evaluation of 11C-labeled 1,3-dihydro-2H-benzo[d]imidazole-2-ones for imaging \u03b38-dependent transmembrane AMPA receptor regulatory protein","volume":"157","author":"Chen","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0300","first-page":"895","article-title":"Synthesis of \u201cno carrier added\u201d 11C-labelled BCNU","volume":"23","author":"Diksic","year":"1982","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF02070202","article-title":"Synthesis of \u201cno-carrier-added\u201d11C-labelled nitrosoureas","volume":"89","author":"Diksic","year":"1985","journal-title":"J Rad Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0310","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jlcr.947","article-title":"Radiosynthesis of carbon-11-labelled GI181771, a new selective CCK-A agonist","volume":"48","author":"Doll\u00e9","year":"2005","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0315","doi-asserted-by":"crossref","first-page":"106122","DOI":"10.1039\/C5RA22500K","article-title":"Radiosynthesis and evaluation of N-(3,4-dimethylisoxazol-5-yl)piperazine-4-[4-(4-fluorophenyl)thiazol-2-yl]-1-[11C]carboxamide for in vivo positron emission tomography imaging of fatty acid amide hydrolase in brain","volume":"5","author":"Shimoda","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0320","author":"Yamasaki","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0325","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1016\/j.bmcl.2014.05.045","article-title":"[11C-carbonyl]CEP-32496: Radiosynthesis, biodistribution and PET study of brain uptake in P-gp\/BCRP knockout mice","volume":"24","author":"Shimoda","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536012118795952","article-title":"Pharmacokinetic evaluation of [11C]CEP-32496 in nude mice bearing BRAFV600E mutation-induced melanomas","volume":"17","author":"Jiang","year":"2018","journal-title":"Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0335","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.7150\/thno.15257","article-title":"Synthesis and preclinical evaluation of sulfonamido-based [11C-carbonyl]carbamates and ureas for imaging monoacylglycerol lipase","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0340","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1016\/j.bmcl.2017.07.040","article-title":"Radiosynthesis and evaluation of new PET ligands for peripheral cannabinoid receptor type 1 imaging","volume":"27","author":"Yamasaki","year":"2017","journal-title":"Bioor Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0345","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/jlcr.718","article-title":"Efficient synthesis of [11C]befloxatone, a selective radioligand for the in vivo imaging of MAO-A density using PET","volume":"46","author":"Doll\u00e9","year":"2003","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0350","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00001756-199305000-00018","article-title":"In vivo visualization of acetylcholinesterase with positron emission tomography","volume":"4","author":"Tavitian","year":"1993","journal-title":"NeuroReport"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0355","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0969-8043(94)00126-K","article-title":"Radiosynthesis of methyl and heptyl [11C]Isocyanates from [11C]phosgene, application to the synthesis of carbamates: [11C]physostygmine and [11C]heptylphysostigmine","volume":"46","author":"Crouzel","year":"1995","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0360","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/jlcr.504","article-title":"Synthesis and preliminary evaluation of a carbon-11-labelled agonist of the \u03b17 nicotinic acetylcholine receptor","volume":"44","author":"Dolle","year":"2001","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0365","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.nucmedbio.2013.03.004","article-title":"Synthesis, metabolite analysis, and in vivo evaluation of [11C]irinotecan as a novel positron emission tomography (PET) probe","volume":"40","author":"Kawamura","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0370","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neuroimage.2018.05.015","article-title":"First demonstration of in vivo mapping for regional brain monoacylglycerol lipase using PET with [11C]SAR127303","volume":"176","author":"Yamasaki","year":"2018","journal-title":"NeuroImage"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0375","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1021\/acs.jmedchem.7b01400","article-title":"In vitro and in vivo evaluation of 11C-labeled azetidinecarboxylates for imaging monoacylglycerol lipase by PET imaging studies","volume":"61","author":"Cheng","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0380","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1021\/acs.jmedchem.8b01778","article-title":"Design, synthesis, and evaluation of reversible and irreversible monoacylglycerol lipase positron emission tomography (PET) tracers using a \u201ctail switching\u201d strategy on a piperazinyl azetidine skeleton","volume":"62","author":"Chen","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.04.007_bb0385","unstructured":"Mori W, Hatori A, Zhang Y, Fujinaga M, Zhang MR. Development of two new PET radiotracers with different brain kinetics for imaging monoacylglycerol lipase in brain. J Nucl Med (Suppl) 2020."}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805120301190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805120301190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:34:08Z","timestamp":1760848448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805120301190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":77,"alternative-id":["S0969805120301190"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2020.04.007","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[11C]phosgene: Synthesis and application for development of PET radiotracers","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2020.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}